Suppr超能文献

[糖尿病晚期并发症的可能遗传原因]

[Possible genetic causes for late complications of diabetes mellitus].

作者信息

Klemm T, Paschke R

机构信息

Medizinische Klinik und Poliklinik III, Universität Leipzig.

出版信息

Med Klin (Munich). 2000 Jan 15;95(1):31-9. doi: 10.1007/BF03044978.

Abstract

BACKGROUND

Hyperglycemia occurs in every patient with diabetes mellitus. It is the most important factor in the development of diabetic complications. However, the onset, intensity and the progression of complications show large interindividual variations. Manifestation in families and the lack of complications in some diabetics with poor metabolic control indicate a genetic predisposition to develop diabetic complications like nephropathy, neuropathy and angiopathy.

NEPHROPATHY

Diabetic nephropathy occurs only in 25 to 40% of the diabetic patients. Therefore a genetic risk factor for this complication is very likely. Various variations in genes like ACE-gene and angiotensinogen-gene have been described, which could be associated with the development of diabetic nephropathy.

NEUROPATHY

Peripheral diabetic neuropathy occurs in up to 66% of all diabetics. Therefore and because of the possible pathological mechanisms genetic risk factors like variations in the Na/K-ATPase-gene and in the aldose reductase-gene are discussed.

RETINOPATHY

An association between diabetic retinopathy and polymorphisms in the ACE-gene and the aldose reductase-gene seems very unlikely, because up to 75% of the diabetic patients suffer from retinopathy after 15 years of diabetes.

MACROANGIOPATHY

A large number of studies show an association between diabetic macroangiopathy and genetic variations in the ACE-gene (I/D-variant) and the paraoxonase-gene (2 isoforms).

CONCLUSION

Based on the current evidence for associations of genetic markers with diabetic complications, the generation of an individual risk profile based on genetic markers seems to be possible. In addition to near euglycemia genetic markers could direct therapeutic strategies and lead to new therapeutic approaches.

摘要

背景

每位糖尿病患者都会出现高血糖。它是糖尿病并发症发生发展的最重要因素。然而,并发症的发作、严重程度和进展存在很大的个体差异。家族中的表现以及一些代谢控制不佳的糖尿病患者未出现并发症,表明存在发生糖尿病肾病、神经病变和血管病变等糖尿病并发症的遗传易感性。

肾病

仅25%至40%的糖尿病患者会发生糖尿病肾病。因此,这种并发症很可能存在遗传风险因素。已描述了诸如ACE基因和血管紧张素原基因等基因的各种变异,它们可能与糖尿病肾病的发生有关。

神经病变

高达66%的糖尿病患者会发生周围性糖尿病神经病变。因此,鉴于可能的病理机制,人们讨论了诸如钠钾ATP酶基因和醛糖还原酶基因变异等遗传风险因素。

视网膜病变

糖尿病视网膜病变与ACE基因和醛糖还原酶基因多态性之间似乎不太可能存在关联,因为高达75%的糖尿病患者在患糖尿病15年后会出现视网膜病变。

大血管病变

大量研究表明糖尿病大血管病变与ACE基因(I/D变异)和对氧磷酶基因(2种同工型)的遗传变异有关。

结论

基于目前关于遗传标记与糖尿病并发症关联的证据,似乎有可能根据遗传标记生成个体风险概况。除了接近正常血糖水平外,遗传标记还可以指导治疗策略并带来新的治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验